Inhibition of the NLRP3 inflammasome by GAS has been demonstrated in vivo and in vitro using animal models of myocardial ischemia, cerebral ischemia, fulminant hepatitis, traumatic brain injury, septic shock, and cognitive dysfunction [7–9, 36–38]. Here, NLRP3 is linked to Fulminant hepatitis.